RU2000102642A - MEDICAL MEANS AGAINST AloPETIA - Google Patents
MEDICAL MEANS AGAINST AloPETIAInfo
- Publication number
- RU2000102642A RU2000102642A RU2000102642/14A RU2000102642A RU2000102642A RU 2000102642 A RU2000102642 A RU 2000102642A RU 2000102642/14 A RU2000102642/14 A RU 2000102642/14A RU 2000102642 A RU2000102642 A RU 2000102642A RU 2000102642 A RU2000102642 A RU 2000102642A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- treatment
- hirsutism
- seborrhea
- female
- Prior art date
Links
- 206010020112 Hirsutism Diseases 0.000 claims 13
- 208000008742 Seborrheic Dermatitis Diseases 0.000 claims 13
- 206010039792 Seborrhoea Diseases 0.000 claims 13
- 201000004384 alopecia Diseases 0.000 claims 13
- 231100000360 alopecia Toxicity 0.000 claims 13
- 210000000988 Bone and Bones Anatomy 0.000 claims 10
- 206010027476 Metastasis Diseases 0.000 claims 10
- 206010060862 Prostate cancer Diseases 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 239000004480 active ingredient Substances 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
Claims (24)
где R1 и R2 являются одинаковыми или отличаются друг от друга, и каждый представляет атом водорода, гидроксильную группу, защищенную гидроксильную группу или низшую алкоксигруппу, или его фармацевтически приемлемую соль или другое его производное.1. Composition for the treatment of alopecia, female-type hirsutism or seborrhea, or to prevent bone metastasis caused by prostate cancer, containing as active ingredient a compound represented by formula (I)
where R 1 and R 2 are the same or different from each other, and each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof or another derivative thereof.
где R1 и R2 являются одинаковыми или отличаются друг от друга, и каждый представляет атом водорода, гидроксильную группу, защищенную гидроксильную группу или низшую алкоксигруппу, или его фармацевтически приемлемой соли или другого его производного, для получения композиции для лечения алопеции, гирсутизма по женскому типу или себореи, или для предупреждения метастаза в кости, вызванного раком предстательной железы.9. The use of compounds represented by formula (I)
where R 1 and R 2 are the same or different from each other, and each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group or a lower alkoxy group, or a pharmaceutically acceptable salt or other derivative thereof, to produce a composition for treating alopecia, hirsutism type or seborrhea, or to prevent bone metastasis caused by prostate cancer.
где R1 и R2 являются одинаковыми или отличаются друг от друга, и каждый представляет атом водорода, гидроксильную группу, защищенную гидроксильную группу или низшую алкоксигруппу, или его фармацевтически приемлемую соль или другое его производное.17. A method of treating alopecia, female-type hirsutism or seborrhea, or prevention of bone metastasis caused by prostate cancer, comprising administering to a warm-blooded animal in need of such treatment or prevention, a therapeutically effective amount of the active ingredient, where said active ingredient is a compound, represented by the formula (I)
where R 1 and R 2 are the same or different from each other, and each represents a hydrogen atom, a hydroxyl group, a protected hydroxyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof or another derivative thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20313697 | 1997-07-29 | ||
| JP9/203136 | 1997-07-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2000102642A true RU2000102642A (en) | 2001-11-10 |
| RU2193887C2 RU2193887C2 (en) | 2002-12-10 |
Family
ID=16469018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2000102642/14A RU2193887C2 (en) | 1997-07-29 | 1998-07-27 | Medicinal agent against alopecia |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6380179B1 (en) |
| EP (1) | EP0998930B1 (en) |
| KR (1) | KR20010022066A (en) |
| CN (1) | CN1129433C (en) |
| AT (1) | ATE262337T1 (en) |
| AU (1) | AU733830B2 (en) |
| BR (1) | BR9811293A (en) |
| CA (1) | CA2298851A1 (en) |
| DE (1) | DE69822636T2 (en) |
| DK (1) | DK0998930T3 (en) |
| ES (1) | ES2218840T3 (en) |
| HK (1) | HK1027290A1 (en) |
| HU (1) | HUP0003159A3 (en) |
| ID (1) | ID24566A (en) |
| IL (1) | IL134199A0 (en) |
| NO (1) | NO20000469L (en) |
| NZ (1) | NZ502537A (en) |
| PL (1) | PL338414A1 (en) |
| PT (1) | PT998930E (en) |
| RU (1) | RU2193887C2 (en) |
| TR (1) | TR200000263T2 (en) |
| WO (1) | WO1999006050A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0963998T3 (en) * | 1997-02-26 | 2004-08-16 | Sankyo Co | Azasteroid compound for the treatment or prevention of prostate cancer |
| JP2007518827A (en) * | 2004-02-02 | 2007-07-12 | シェーリング コーポレイション | Method for modulating CD200 and CD200R |
| US20080108681A1 (en) * | 2006-10-27 | 2008-05-08 | Access Business Group International Llc | Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions |
| CA3045407C (en) | 2009-07-29 | 2024-03-12 | Elise A. Olsen | Compositions and methods for inhibiting hair growth |
| MX2010012945A (en) * | 2010-11-24 | 2012-05-24 | Fidel Ojeda Gomez | Formulation for controlling and eliminating seborrhea and alopecia on the scalp. |
| RU2477155C2 (en) * | 2011-04-27 | 2013-03-10 | Закрытое акционерное общество "Патент-Фарм" | Method of treating androgenetic alopecia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571817A (en) | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
| US5516768A (en) | 1990-03-16 | 1996-05-14 | Smithkline Beecham Corporation | Uncompetitive inhibition of steroid and 5α-reductose |
| IE76452B1 (en) * | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
| JP3030152B2 (en) * | 1992-02-03 | 2000-04-10 | 三共株式会社 | 4-azasteroid compounds |
| TW382595B (en) | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
| JPH0873492A (en) * | 1994-06-28 | 1996-03-19 | Sankyo Co Ltd | Azasteroids |
| US5629007A (en) | 1995-03-21 | 1997-05-13 | Eli Lilly And Company | Method of preventing prostatic cancer development |
| US5635197A (en) | 1995-03-21 | 1997-06-03 | Eli Lilly And Company | Treatment and prevention of prostatic cancer metastasis |
| AU7078296A (en) | 1995-09-27 | 1997-04-17 | Merck & Co., Inc. | Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors |
| RU2154467C2 (en) * | 1996-02-05 | 2000-08-20 | Санкио Компани Лимитед | COMPOSITION OF INHIBITOR OF 5α-REDUCTASE FOR ORAL ADMINISTRATION, METHOD OF ITS PREPARING AND USE |
| DK0963998T3 (en) * | 1997-02-26 | 2004-08-16 | Sankyo Co | Azasteroid compound for the treatment or prevention of prostate cancer |
| US6093722A (en) | 1997-02-26 | 2000-07-25 | Sankyo Company, Limited | Method for treating prostate cancer |
-
1998
- 1998-07-27 ES ES98933945T patent/ES2218840T3/en not_active Expired - Lifetime
- 1998-07-27 DE DE69822636T patent/DE69822636T2/en not_active Expired - Fee Related
- 1998-07-27 DK DK98933945T patent/DK0998930T3/en active
- 1998-07-27 NZ NZ502537A patent/NZ502537A/en unknown
- 1998-07-27 ID IDW20000167A patent/ID24566A/en unknown
- 1998-07-27 BR BR9811293-7A patent/BR9811293A/en not_active IP Right Cessation
- 1998-07-27 PL PL98338414A patent/PL338414A1/en unknown
- 1998-07-27 IL IL13419998A patent/IL134199A0/en unknown
- 1998-07-27 CA CA002298851A patent/CA2298851A1/en not_active Abandoned
- 1998-07-27 RU RU2000102642/14A patent/RU2193887C2/en not_active IP Right Cessation
- 1998-07-27 AU AU83585/98A patent/AU733830B2/en not_active Ceased
- 1998-07-27 PT PT98933945T patent/PT998930E/en unknown
- 1998-07-27 EP EP98933945A patent/EP0998930B1/en not_active Expired - Lifetime
- 1998-07-27 CN CN98809366A patent/CN1129433C/en not_active Expired - Fee Related
- 1998-07-27 WO PCT/JP1998/003337 patent/WO1999006050A1/en not_active Application Discontinuation
- 1998-07-27 HU HU0003159A patent/HUP0003159A3/en unknown
- 1998-07-27 KR KR1020007000635A patent/KR20010022066A/en not_active Application Discontinuation
- 1998-07-27 AT AT98933945T patent/ATE262337T1/en not_active IP Right Cessation
- 1998-07-27 TR TR2000/00263T patent/TR200000263T2/en unknown
-
2000
- 2000-01-28 NO NO20000469A patent/NO20000469L/en not_active Application Discontinuation
- 2000-01-28 US US09/493,488 patent/US6380179B1/en not_active Expired - Fee Related
- 2000-10-10 HK HK00106422A patent/HK1027290A1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU90956I2 (en) | Metvix active ingredient methylaminolevulinic in the form of a salt preferably methylaminolevulinic hydrochloride | |
| ES2295609T3 (en) | TIADIAZOLILPIPERAZINA DERIVATIVES USEFUL TO TREAT OR PREVENT A PAIN. | |
| RU94044671A (en) | Use of nonpeptide antagonists of tachykinin receptors | |
| WO2004029031A3 (en) | Therapeutic piperazine compounds | |
| HK1091481A1 (en) | Therapeutic agents useful for treating pain | |
| RU94045149A (en) | Agent for inhibition of pulmonary hypertension diseases | |
| WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
| RU94044453A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for seborrhea and acne inhibition | |
| RU94044454A (en) | Inhibitor of autoimmune diseases | |
| EE200000472A (en) | Antineoplastic agents | |
| EP0779889A4 (en) | PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE | |
| AP2002002387A0 (en) | Method of inhibiting amyloid aggregation and imaging amyloid deposits. | |
| RU2000102642A (en) | MEDICAL MEANS AGAINST AloPETIA | |
| RU94045156A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for premature sexual maturation inhibition | |
| RU99118510A (en) | COMPOSITION FOR THE TREATMENT OR PREVENTION OF PROSTATE CANCER | |
| RU2007143434A (en) | 4-ANILINO-3-CHINOLINE CARBONITRILS SUITABLE FOR TREATING CANCER DISEASES | |
| IL105122A0 (en) | Benzimidazole derivative for use as an anti-irritant | |
| RU94044457A (en) | Use of benzthiophenes for hirsutism and alopecia inhibition | |
| NO983217L (en) | Therapeutic anti-asthma agents containing selenium compounds | |
| RU99113432A (en) | NEW DERIVATIVES OF PHENANTRIDINIA | |
| WO2001007029A3 (en) | Substituted guanidines and the use thereof | |
| RU96107794A (en) | TRIARILETHYLENE DERIVATIVES FOR USE IN THERAPY | |
| RU97112862A (en) | Pyrimidine derivatives | |
| RU97113495A (en) | APPLICATION OF 3,4-DIPHENYL CHROMANS FOR OBTAINING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF IDIOPATHIC OR PHYIOLOGICAL GYNECOMMOSTIA | |
| RU94011231A (en) | Triple substituted derivatives of cycloalkane and method of their preparation |